It is a known brand with a product and business model that the masses understand and need. It again highlights our severe lack of comms and investor relations strategy. The companies diligence and caution not to overhype means the balance of getting the story out and generating interest is simply not met.
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-11761
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B |
Open | High | Low | Value | Volume |
$17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 598 | $16.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.87 | 1676 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 598 | 16.700 |
1 | 9588 | 16.680 |
1 | 1380 | 16.670 |
1 | 468 | 16.660 |
1 | 50 | 16.600 |
Price($) | Vol. | No. |
---|---|---|
16.870 | 1676 | 1 |
16.880 | 1600 | 2 |
16.910 | 1676 | 1 |
16.950 | 1676 | 1 |
16.980 | 1900 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online